Timing of Referral to Early Intervention Services in Infants With Severe Bronchopulmonary Dysplasia.


Journal

Clinical pediatrics
ISSN: 1938-2707
Titre abrégé: Clin Pediatr (Phila)
Pays: United States
ID NLM: 0372606

Informations de publication

Date de publication:
10 2019
Historique:
pubmed: 8 8 2019
medline: 23 5 2020
entrez: 8 8 2019
Statut: ppublish

Résumé

This study is a secondary analysis of an observational prospective case series of 50 infants with severe bronchopulmonary dysplasia that describes patient factors associated with the time between initial hospital discharge and referral to early intervention (EI) services. It also evaluates associations between (1) timing of EI referral and reception of EI services and (2) early referral to EI and developmental outcomes at 18 to 36 months corrected age. The results demonstrated that a referral from a neonatologist versus a pediatrician was associated with fewer days between discharge and EI referral. Earlier EI referrals were associated with a shorter time to intake evaluation and service initiation. The Bayley-III (Bayley Scales of Infant and Toddler Development, 3rd Edition) scores at 24 months corrected age (n = 28) were not associated with timing of EI referral. In conclusion, an early referral to EI promoted earlier evaluation and initiation of EI services and should be standard for high-risk infants.

Identifiants

pubmed: 31387391
doi: 10.1177/0009922819867460
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1224-1231

Auteurs

Valerie Martin (V)

Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Jennifer M Brady (JM)

University of Cincinnati, Cincinnati, OH, USA.
Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Kelcy Wade (K)

Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Marsha Gerdes (M)

Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Sara B DeMauro (SB)

Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH